BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8405482)

  • 1. Bioreduction of RSU 1069 and mitomycin C after dearterialization.
    Wang LQ; Persson BG; Bengmark S
    Eur J Surg Oncol; 1993 Oct; 19(5):455-62. PubMed ID: 8405482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rearterialization of liver tumors after various dearterialization procedures.
    Wang LQ; Persson BG; Bergqvist L; Bengmark S
    J Surg Res; 1994 Oct; 57(4):454-9. PubMed ID: 7523766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of portal branch ligation on the outcome of repeat dearterializations of an experimental liver tumor in the rat.
    Wang LQ; Persson BG; Stenram U; Bengmark S
    J Surg Oncol; 1994 Apr; 55(4):229-34. PubMed ID: 7512673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of portal deviation on the effect of repeat dearterializations of a transplantable adenocarcinoma to the rat liver.
    Wang LQ; Persson BG; Bengmark S
    HPB Surg; 1994; 8(1):37-41. PubMed ID: 7993863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated dearterializations of an experimental liver tumor: short- and long-term results.
    Wang LQ; Persson BG; Jeppsson B; Bengmark S
    J Surg Res; 1994 Jan; 56(1):53-9. PubMed ID: 8277769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C and lipiodol do not improve the effect of intermittent hepatic artery occlusion on liver tumour growth. An experimental study in the rat.
    Sjövall S; Foss A; Audisio R; Ahrén B; Bengmark S
    Anticancer Res; 1991; 11(5):1823-5. PubMed ID: 1662927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of hepatic arterial supply in rats with liver tumors.
    Carlsson G; Hafström L
    Acta Chir Scand; 1982; 148(7):609-12. PubMed ID: 7168291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.
    Wong KH; Koch CJ; Wallen CA; Wheeler KT
    Br J Cancer; 1991 Apr; 63(4):484-8. PubMed ID: 2021530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy.
    Henry JM; Isaacs JT
    J Urol; 1989 Jul; 142(1):165-70. PubMed ID: 2733098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
    Keohane A; Godden J; Stratford IJ; Adams GE
    Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT).
    Chaplin DJ
    Br J Cancer; 1986 Nov; 54(5):727-31. PubMed ID: 3801269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione and phospholipid depletion of liver tumors after arterial ischemia.
    Wang LQ; Persson BG; Xu N; Seidegård J; Jeppsson B; Bengmark S
    J Surg Oncol; 1996 Apr; 61(4):284-9. PubMed ID: 8628000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver blood flow after liver hilus dearterialization.
    Höckerstedt K; Nieminen J; Scheinin TM
    Ann Chir Gynaecol; 1978; 67(6):224-8. PubMed ID: 742825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP; Gulyas S; Whitmore GF
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver hilus dearterialization. A histological and electron microscopical study in the dog.
    Höckerstedt K; Korsbäck C; Lehto VP
    Ann Chir Gynaecol; 1979; 68(1):23-32. PubMed ID: 475301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
    Binger M; Workman P
    Cancer Chemother Pharmacol; 1991; 29(1):37-47. PubMed ID: 1742848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic artery occlusion for liver cancer.
    Hafström L; Carlsson G; Gustavsson B; Holmberg S
    Ann Chir Gynaecol; 1983; 72(5):239-45. PubMed ID: 6362547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First experiments with locoregional chemotherapy in the treatment of autochthonous rat hepatoma.
    Rozycki-Gerlach W; Berger MR; Friedl P; Yi J; Schmähl D; Schlag P
    Arch Geschwulstforsch; 1988; 58(6):369-78. PubMed ID: 2464971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dearterialization on distribution of absolute tumor blood flow between hepatic artery and portal vein.
    Wang LQ; Persson BG; Bergqvist L; Bengmark S
    Cancer; 1994 Nov; 74(9):2454-9. PubMed ID: 7923000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose turnover in rats undergoing transient dearterialization for liver malignancy.
    Mack P; Ahrén B; Jeppsson B; Bengmark S
    J Surg Res; 1989 Nov; 47(5):447-52. PubMed ID: 2811358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.